GlassScriptPhysician profile
Hannah Kasunic
NPI 1588289979
$5,208.92
in general payments reported to CMS, 2019-2025
26 companies · $884 in 2025
The $884 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.21 · 2022: $2,193 · 2023: $1,393 · 2024: $724 · 2025: $884.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,354 · Travel and Lodging: $558 · Education: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,353.99 |
| Travel and Lodging | $557.63 |
| Education | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,761.09 | 2022-2024 | Bulkamid, Axonics |
| Medtronic, INC. | $825.01 | 2023 | Interstim |
| Janssen Biotech, INC. | $503.57 | 2022-2025 | Erleada |
| Abbvie INC. | $296.25 | 2022-2025 | |
| Calyxo, INC. | $205.56 | 2024-2025 | Cvac Aspiration System |
| Astellas Pharma US INC | $198.29 | 2022-2023 | Myrbetriq, Xtandi |
| Procept Biorobotics Corporation | $166.11 | 2025 | |
| Antares Pharma, INC. | $164.47 | 2024-2025 | Xyosted |
| Sumitomo Pharma America, INC. | $149.02 | 2023-2025 | Gemtesa, Orgovyx |
| Baxter Healthcare | $129.66 | 2022-2023 | Perclot |
| Teleflex LLC | $116.24 | 2024 | Urolift |
| Urogen Pharma, INC. | $112.76 | 2022-2025 | Jelmyto |
| Boston Scientific Corporation | $90.23 | 2023-2024 | Lithovue |
| Merck Sharp & Dohme LLC | $81.78 | 2025 | Keytruda |
| Urovant Sciences INC | $70.63 | 2021-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $66.36 | 2022-2023 | |
| Ferring Pharmaceuticals INC. | $60.57 | 2025 | Adstiladrin |
| Endo USA, INC. | $54.74 | 2025 | Xiaflex |
| Emd Serono, INC. | $25.91 | 2025 | |
| Olympus America INC. | $25.37 | 2025 | Itind System |
| Accord Healthcare, INC. | $20.95 | 2025 | |
| Sun Pharmaceutical Industries INC. | $20.22 | 2024 | |
| Endo Pharmaceuticals INC. | $17.12 | 2022 | |
| Azurity Pharmaceuticals, INC. | $17.00 | 2025 | Azmiro |
| Myriad Genetic Laboratories, INC. | $15.65 | 2022 | |
| Intuitive Surgical, INC. | $14.36 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Kasunic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.